# To Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies

Source: https://onco.cc/trials/nct07795034/  
OnCo record `nct07795034` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of Boron Neutron Capture Therapy in head and neck squamous cell carcinoma, run by Neuboron Bio-SciTech Co., Ltd., now recruiting.

## Summary

To Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies is a phase 2 interventional study registered as NCT07795034 by Neuboron Bio-SciTech Co., Ltd., with 35 participants planned, started 2026-08-31 and due to reach its primary completion in 2027-08. Interventions recorded: Boron Neutron Capture Therapy.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: pipeline; ctgov-ingest
- Registry id: NCT07795034
- Phase: 2
- Setting: A Single-Arm, Open-Label Phase II Clinical Trial to Evaluate the Efficacy and Safety of Accelerator-Based Boron Neutron Capture Therapy (AB-BNCT) Combined With NBB-001 and NBB-002 for Patients With Recurrent Head and Neck Malignancies
- Sponsor: Neuboron Bio-SciTech Co., Ltd.
- Enrolled: 35

## Sources

- ClinicalTrials.gov NCT07795034: https://clinicaltrials.gov/study/NCT07795034

## Connected records

- cancers: [Head and neck squamous cell carcinoma](https://onco.cc/cancers/head-and-neck/)

---
JSON: https://onco.cc/api/v1/entities/nct07795034.json